Zoloft

  • Zoloft Medical Record Review & Outsourcing Services

Zoloft (sertraline hydrochloride), an antidepressant, is a class of drugs called selective serotonin reuptake inhibitors (SSRIs). Pfizer started manufacturing Sertraline in the early '90s. In 1999, the Food and Drug Administration (FDA) approved it as an antidepressant. This drug affects chemicals in the brain that may become unbalanced and cause depression, panic, anxiety, or obsessive-compulsive symptoms. In 2013, it was the most prescribed antidepressant. It is administered both in adults and children to treat conditions such as depression, obsessive-compulsive disorder, post-traumatic stress disorder, and anxiety.

Serious Alleged Injuries may include:

  • Psychiatric problems
  • Abnormal blood pressure
  • Physical deformities
  • Stomach problems
  • Hearing Loss
  • Cleft lip, Cleft palate, Clubfoot, webbed toes
  • Vision problems
  • Skull deformities
  • Heart defects

FDA Safety Warnings:

Since the drug's introduction, the FDA has issued safety alerts regarding unreported side effects of Zoloft, which was seen to cause certain unexpected injuries to the babies born when their mothers had consumed this drug during pregnancy.

In 2011, the FDA reported a Safety warning regarding the use of SSRI in pregnancy and rare heart and lung condition in newborn babies.

Legal Updates:

Defendants: Pfizer Inc.

Defendant Law Firm: Mark S. Cheffo, Esq. Quinn Emanuel Urquhart & Sullivan, LLP

Allegations: Allegations include that Zoloft manufacturers failed to warn about the side effects ranging from less severe symptoms, like stomach cramps and drowsiness, to life-threatening problems such as suicidal thoughts and heart problems. Also, other allegations include injuries in children whose mother took the drug while pregnant.

Plaintiff Steering Committee:

  • Joseph J. Zonies, Esq. Reilly Pozner LLP

  • Sean Patrick Tracey, Esq. Tracey Law Firm

  • Kimberly D. Barone Baden, Esq. Motley Rice LLC

  • Andy D. Birchfield, Jr., Esq. Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

  • Edward F. Blizzard, Esq. Blizzard, McCarthy & Nabers

  • Edward Braniff, Esq. Weitz & Luxemberg

  • Thomas P. Cartmell, Esq. Wagstaff & Cartmell

  • Christopher L. Coffin, Esq. Pendley, Baudin & Coffin, L.L.P.

  • Jayne Conroy, Esq. Hanly Conroy Bierstein Sheridan Fisher & Hayes LLP

  • Arnold Levin, Esq. Levin, Fishbein, Sedran & Berman

  • David F. Miceli, Esq. Simmons Browder Gianaris Angelides and Barnerd, LLC

  • Stephanie O’Connor, Esq. Douglas & London, P.C.

  • Christopher A. Seeger, Esq. Seeger Weiss LLP

Lawsuit Status: All the cases in MDL are dismissed

Important Verdicts & Settlements: 

April 17, 2012: The Judicial Panel on Multidistrict Litigation consolidated lawsuits alleging birth defects. The cases were presided by Judge Cynthia M. Rufe consolidated in MDL No. 2342 (In Re: Zoloft Sertraline Hydrochloride). There were more than 700 federal cases listed in the MDL.

January 2013: A class-action lawsuit was filed in the federal court in California with similar allegations. However, the lawsuit was dismissed in 2014.

November 2017: The federal MDL cases were dismissed or withdrawn on account of the failure of adequate evidence.

Evidence:

  • Duration of Zoloft usage in pregnant females from Medical Records
  • Usage of Zoloft and other antidepressants in Pharmacy Records
  • Diagnosis and Treatment of birth anomalies after Zoloft Intake
  • Treatment required for the birth related defects in affected child

Medical Record Review and claim validation of Zoloft case should take approximately 3 hours in most instances; however, this approximation may vary in cases based on the volume of records.

Accreditations

HIPAA

Neural IT has successfully implemented HIPAA for securing Health records....

ISO 27001 Certification

Neural IT has successfully passed the ISMS re-certification audit and is now ISO 27001:2013 certi...

NSIC - CRISIL

NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...

Associations

CAALA

CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...

CAOC

CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...

NYSTLA

NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...

News & Events

Rewards & Recognition Program - July 2019
Neural IT organized ‘Rewards & Recognition Program' on July 5, 2019, to motivate employees an
International Yoga Day - Image - Neural IT
International Yoga Day celebrated at Neural IT to bring physical and emotional health for our tea
MTMP April 2019
Neural IT shared presence with Mike Papantonio at the spectacular 3-day conferenc

Latest Tweets